Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications

Journal of Clinical Oncology

Volumn 23, Issue 6, 2005, Pages 1289-1294

  Geling, Olga ^a   Eichler, Hans Georg ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ONDANSETRON; PLACEBO; SEROTONIN 3 ANTAGONIST; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; SEROTONIN 3 RECEPTOR;

ADD ON THERAPY; ARTICLE; CHEMOTHERAPY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING; COST BENEFIT ANALYSIS; DRUG ANTAGONISM; DRUG COMBINATION; TIME;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DEXAMETHASONE; DRUG COSTS; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, SEROTONIN, 5-HT3; TIME FACTORS;

EID: 14544288652     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.022     Document Type: Article

References (23)

1. Gralla RJ, Osoba D, Kris MG, et al: ASCO: Recommendations for use of antiemetics-Evidence-based clinical practice guidelines. J Clin Oncol 17:2971-2994, 1999
2. Italian Group for Antiemetic Research: Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting. Ann Oncol 9:759-765, 1998
3. Grunberg SM, Deuson RR, Mavros P, et al: Incidence of chemotherapy-induced nausea and emesis after modern antiemetics: Perception versus reality. Cancer 100:2261-2268, 2004
4. 3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. Practice Guideline Report 12-3. http://www.cancercare. on.ca/pdf/full12_3.pdf
5. Gandara DR, Harvey WH, Monaghan GG, et al: The delayed-emesis syndrome from cisplatin: Phase III evaluation of ondansetron versus placebo. Semin Oncol 19:67-71, 1992 (suppl 10)
6. Kaizer L, Warr D, Hoskins P, et al: Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: A phase III trial by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:1050-1057, 1994
7. Navari RM, Madajewicz S, Anderson N, et al: Oral ondansetron for the control of cisplatin-induced delayed emesis: A large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo. J Clin Oncol 13:2408-2416, 1995
8. Stewart A, McQuade B, Cronje JD, et al: Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: A multicenter, double-blind, double-dummy, randomized, parallel-group study. Oncology 52:202-210, 1995
9. Olver I, Paska W, Depierre A, et al: A multicenter, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ann Oncol 7:945-952, 1996
10. 3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Ann Oncol 8:181-185, 1997
11. Sorbe BG, Berglind AM, Andersson H, et al: A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis. Cancer 83:1022-1032, 1998
12. Goedhals L, Heron JF, Kleisbauer JP, et al: Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study. Ann Oncol 9:661-666, 1998
13. Latreille J, Pater J, Johnston D, et al: Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy: National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 16:1174-1178, 1998
14. Italian Group for Antiemetic Research: Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N Engl J Med 342:1554-1559, 2000
15. MASCC: Prevention of chemotherapy-and radiology-induced emesis: Results of the Perugia Consensus Conference. Ann Oncol 6:215-220, 1998
16. Cook RJ, Sackett DL: The number needed to treat a clinically useful measure of treatment effect. BMJ 310:452-454, 1995
17. Ioannidis JPA, Hesketh PJ, Lau J: Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: A meta-analysis of randomized evidence. J Clin Oncol 18:3409-3422, 2000
18. Kris MG, Grall RJ, Tyson LB, et al: Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7:108-114, 1989
19. Koo WH, Ang PT: Role of maintenance dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy. Ann Oncol 7:71-74, 1996
20. Gridelli C, Maione P, Rossi A: Corticosteroids underemployment in delayed-induced nausea and emesis with poor adherence to American Society of Clinical Oncology Guidelines: Is this a reasonable clinical choice for the elderly? J Clin Oncol 21:4066-4069, 2003
21. Mertens WC, Higby DJ, Brown D, et al: Improving the care of patients with regard to chemotherapy-induced nausea and emesis: The effect of feedback to clinicians on adherence to antiemetic prescribing guidelines. J Clin Oncol 21:1373-1378, 2003
22. Roscoe JA, Morrow GR, Hickok JT, et al: Nausea and vomiting remain a significant clinical problem: Trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage 20:113-121, 2000
23. Tsukada H, Hirose T, Yokoyama A, et al: Randomized comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis. Eur J Cancer 37:2398-2404, 2001